Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 371,247 |
|
|||||
| News | - | ||||||
| Day High | 1.22 | Low High |
|||||
| Day Low | 1.155 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Protalix BioTherapeutics Inc | PLX | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.07 | -5.69% | 1.16 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.215 | 1.155 | 1.22 | 1.16 | 1.23 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,903 | 371,247 | US$ 1.19 | US$ 443,405 | - | 1.0308 - 2.505 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:21:52 | 10 | US$ 1.16 | USD |
Protalix BioTherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 86.2M | 73.05M | - | 65.49M | 8.31M | 0.11 | 10.37 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Protalix BioTherapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PLX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.37 | 1.155 | 1.24 | 429,769 | -0.04 | -3.33% |
| 1 Month | 1.20 | 1.37 | 1.0308 | 1.16 | 486,176 | -0.04 | -3.33% |
| 3 Months | 1.54 | 1.56 | 1.0308 | 1.23 | 421,639 | -0.38 | -24.68% |
| 6 Months | 1.41 | 1.90 | 1.0308 | 1.39 | 350,673 | -0.25 | -17.73% |
| 1 Year | 2.08 | 2.505 | 1.0308 | 1.73 | 549,782 | -0.92 | -44.23% |
| 3 Years | 2.90 | 3.55 | 0.70 | 1.71 | 1,024,264 | -1.74 | -60.00% |
| 5 Years | 0.39 | 7.02 | 0.17 | 1.97 | 824,898 | 0.77 | 197.44% |
Protalix BioTherapeutics Description
| Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis.The company's primary sources of revenues include its sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement. |
